Marella Thorell - 01 Jul 2024 Form 4 Insider Report for Carisma Therapeutics Inc. (CARM)

Reporting relationship: Director
Issuer ticker: CARM
Reported as of: 01 Jul 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jul 2024, 19:19:29 UTC
Prior SEC filing: 01 Jul 2024
Next SEC filing: 11 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Eric Siegel, as Attorney-in-Fact for Marella Thorell

Key filing fact

Marella Thorell filed Form 4 for Carisma Therapeutics Inc. (CARM) on 01 Jul 2024.

Key facts

This page summarizes Marella Thorell's Form 4 filing for Carisma Therapeutics Inc. (CARM).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Jul 2024, 19:19.

Change

Previous filing in this sequence was filed on 01 Jul 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CARM transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +38,700
Change %
Price: $0.000000
Shares after: 38,700
Date: 01 Jul 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 38,700
Exercise price: $1.67
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this option vest over three years in equal monthly installments following July 1, 2024, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.